These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 14643976)

  • 1. Encapsulation and release of the hypnotic agent zolpidem from biodegradable polymer microparticles containing hydroxypropyl-beta-cyclodextrin.
    Trapani G; Lopedota A; Boghetich G; Latrofa A; Franco M; Sanna E; Liso G
    Int J Pharm; 2003 Dec; 268(1-2):47-57. PubMed ID: 14643976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complexation of zolpidem with 2-hydroxypropyl-beta-, methyl-beta-, and 2-hydroxypropyl-gamma-cyclodextrin: effect on aqueous solubility, dissolution rate, and ataxic activity in rat.
    Trapani G; Latrofa A; Franco M; Pantaleo MR; Sanna E; Massa F; Tuveri F; Liso G
    J Pharm Sci; 2000 Nov; 89(11):1443-51. PubMed ID: 11015689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a cyclodextrin-based nasal delivery system for lorazepam.
    Jug M; Bećirević-Laćan M
    Drug Dev Ind Pharm; 2008 Aug; 34(8):817-26. PubMed ID: 18622800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of different cyclodextrins on the morphology, loading and release properties of poly (DL-lactide-co-glycolide)-microparticles containing the hypnotic agent etizolam.
    Lopedota A; Cutrignelli A; Trapani A; Boghetich G; Denora N; Laquintana V; Trapani G; Liso G
    J Microencapsul; 2007 May; 24(3):214-24. PubMed ID: 17454433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of formulation parameters on 2-methoxyestradiol release from injectable cylindrical poly(DL-lactide-co-glycolide) implants.
    Desai KG; Mallery SR; Schwendeman SP
    Eur J Pharm Biopharm; 2008 Sep; 70(1):187-98. PubMed ID: 18472254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a 2-HP-β-Cyclodextrin Formulation on the Biological Transport and Delivery of Chemotherapeutic PLGA Nanoparticles.
    Zheng K; Huang Z; Huang J; Liu X; Ban J; Huang X; Luo H; Chen Z; Xie Q; Chen Y; Lu Z
    Drug Des Devel Ther; 2021; 15():2605-2618. PubMed ID: 34168432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inclusion complexation of lorazepam with different cyclodextrins suitable for parenteral use.
    Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
    Drug Dev Ind Pharm; 2005 Jul; 31(6):567-75. PubMed ID: 16109630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eudragit RS 100 microparticles containing 2-hydroxypropyl-beta-cyclodextrin and glutathione: physicochemical characterization, drug release and transport studies.
    Trapani A; Laquintana V; Denora N; Lopedota A; Cutrignelli A; Franco M; Trapani G; Liso G
    Eur J Pharm Sci; 2007 Jan; 30(1):64-74. PubMed ID: 17118631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLGA microparticles encapsulating prostaglandin E1-hydroxypropyl-β-cyclodextrin (PGE1-HPβCD) complex for the treatment of pulmonary arterial hypertension (PAH).
    Gupta V; Davis M; Hope-Weeks LJ; Ahsan F
    Pharm Res; 2011 Jul; 28(7):1733-49. PubMed ID: 21626061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zolpidem Mucoadhesive Formulations for Intranasal Delivery: Characterization, In Vitro Permeability, Pharmacokinetics, and Nasal Ciliotoxicity in Rats.
    Wang Y; Li M; Qian S; Zhang Q; Zhou L; Zuo Z; Lee B; Toh M; Ho T
    J Pharm Sci; 2016 Sep; 105(9):2840-2847. PubMed ID: 27189774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sponge like microparticles for drug delivery and cosmeto-textile use: Formulation and human skin penetration.
    Zafar N; Robin S; Viennet C; Humbert P; Valour JP; Agusti G; Fessi H; Elaissari A
    Int J Pharm; 2017 Oct; 532(1):623-634. PubMed ID: 28870768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
    Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
    Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysozyme stability in primary emulsion for PLGA microsphere preparation: effect of recovery methods and stabilizing excipients.
    Kang F; Jiang G; Hinderliter A; DeLuca PP; Singh J
    Pharm Res; 2002 May; 19(5):629-33. PubMed ID: 12069165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, characterization, pharmacokinetics, and bioactivity of honokiol-in-hydroxypropyl-β-cyclodextrin-in-liposome.
    Wang X; Deng L; Cai L; Zhang X; Zheng H; Deng C; Duan X; Zhao X; Wei Y; Chen L
    J Pharm Sci; 2011 Aug; 100(8):3357-3364. PubMed ID: 21387317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro release of adriamycin from star-shaped poly(lactide-co-glycolide) nano- and microparticles.
    Mooguee M; Omidi Y; Davaran S
    J Pharm Sci; 2010 Aug; 99(8):3389-97. PubMed ID: 20229603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encapsulation in lipospheres of the complex between butyl methoxydibenzoylmethane and hydroxypropyl-beta-cyclodextrin.
    Scalia S; Tursilli R; Sala N; Iannuccelli V
    Int J Pharm; 2006 Aug; 320(1-2):79-85. PubMed ID: 16713145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in burst release after coating poly(D,L-lactide-co-glycolide) (PLGA) microparticles with a drug-free PLGA layer.
    Ahmed AR; Elkharraz K; Irfan M; Bodmeier R
    Pharm Dev Technol; 2012; 17(1):66-72. PubMed ID: 20854130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation, characterization, and pharmacokinetics study of capsaicin via hydroxypropyl-beta-cyclodextrin encapsulation.
    Zhao Y; Sun C; Shi F; Firempong CK; Yu J; Xu X; Zhang W
    Pharm Biol; 2016; 54(1):130-8. PubMed ID: 25853954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complexation with tolbutamide modifies the physicochemical and tableting properties of hydroxypropyl-beta-cyclodextrin.
    Suihko E; Korhonen O; Järvinen T; Ketolainen J; Jarho P; Laine E; Paronen P
    Int J Pharm; 2001 Mar; 215(1-2):137-45. PubMed ID: 11250099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.